Rimegepant is Effective for the Acute Treatment of Migraine in Patients Who Have Discontinued or Currently Use Triptans: Results from 3 Phase 3 Clinical Trials (2114)
Croop R, Jensen C, Thiry A, Stock E, Conway C, Morris B, Coric V, Lipton R. Rimegepant is Effective for the Acute Treatment of Migraine in Patients Who Have Discontinued or Currently Use Triptans: Results from 3 Phase 3 Clinical Trials (2114). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.2114.Peer-Reviewed Original ResearchRimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366)
Pavlovic J, Dodick D, Friedman D, Tepper S, Newman L, Lipton R, Stock E, Thiry A, Conway C, Jensen C, Morris B, Coric V, Croop R. Rimegepant 75 mg Provides Early and Sustained Relief of Migraine With a Single Dose: Results from 3 Phase 3 Clinical Trials (2366). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.2366.Peer-Reviewed Original Research